Press release
Knee Osteoarthritis Pipeline Assessment, 2023 Updates: FDA, EMA, and PMDA Approvals, Emerging Drugs, Clinical Trials, Therapeutic Analysis, and Growth Prospects | Merck KGaA, Peptinov, LG Chem, Akan Bioscience, BioTissue,Inc., Eupraxia Pharmaceuticals Inc
"Knee Osteoarthritis Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Knee Osteoarthritis Market.
The Knee Osteoarthritis Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Some of the key takeaways from the Knee Osteoarthritis Pipeline Report: https://www.delveinsight.com/sample-request/knee-osteoarthritis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Knee Osteoarthritis treatment therapies with a considerable amount of success over the years.
• Knee Osteoarthritis companies working in the treatment market are Merck KGaA, Peptinov, LG Chem, Akan Bioscience, BioTissue,Inc., Eupraxia Pharmaceuticals Inc., OliPass Corporation, Bone Therapeutics, Techfields Pharma, Biosplice Therapeutics, and others, are developing therapies for the Knee Osteoarthritis treatment
• Emerging Knee Osteoarthritis therapies in the different phases of clinical trials are- M6495, PPV 06, LG00034053, StroMel, TTAX03, EP-104IAR, OLP 1002, JTA-004, X 0002, Lorecivivint, and others are expected to have a significant impact on the Knee Osteoarthritis market in the coming years.
• In December 2022, Biosplice Therapeutics, Inc. has disclosed significant findings related to potential structural modifications derived from the continuous observation of an extended study, OA-07, concerning its knee osteoarthritis (OA) treatment candidate, lorecivivint, also known as "LOR." The ongoing study results consistently bolster the likelihood of multiple lorecivivint injections in delaying the deterioration of structural integrity in knee joints and offering symptomatic relief.
Knee Osteoarthritis Overview
Knee osteoarthritis is a degenerative joint condition that affects the knees. It is the most common type of osteoarthritis, a chronic joint disorder characterized by the breakdown of cartilage, the protective tissue that cushions the ends of bones within the joint.
Get a Free Sample PDF Report to know more about Knee Osteoarthritis Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/knee-osteoarthritis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Emerging Knee Osteoarthritis Drugs Under Different Phases of Clinical Development Include:
• M6495: Merck KGaA
• PPV 06: Peptinov
• LG00034053: LG Chem
• StroMel: Akan Bioscience
• TTAX03: BioTissue,Inc.
• EP-104IAR: Eupraxia Pharmaceuticals Inc.
• OLP 1002: OliPass Corporation
• JTA-004: Bone Therapeutics
• X 0002: Techfields Pharma
• Lorecivivint: Biosplice Therapeutics
Knee Osteoarthritis Route of Administration
Knee Osteoarthritis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical
Knee Osteoarthritis Molecule Type
Knee Osteoarthritis Products have been categorized under various Molecule types, such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
Knee Osteoarthritis Pipeline Therapeutics Assessment
• Knee Osteoarthritis Assessment by Product Type
• Knee Osteoarthritis By Stage and Product Type
• Knee Osteoarthritis Assessment by Route of Administration
• Knee Osteoarthritis By Stage and Route of Administration
• Knee Osteoarthritis Assessment by Molecule Type
• Knee Osteoarthritis by Stage and Molecule Type
DelveInsight's Knee Osteoarthritis Report covers around 40+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
Further Knee Osteoarthritis product details are provided in the report. Download the Knee Osteoarthritis pipeline report to learn more about the emerging Knee Osteoarthritis therapies at:
https://www.delveinsight.com/sample-request/knee-osteoarthritis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key companies in the Knee Osteoarthritis Therapeutics Market include:
Key companies developing therapies for Knee Osteoarthritis are - Eli Lilly and Company, Nature Cell Co. Ltd., Novo Nordisk A/S, Flexion Therapeutics, Inc., Grünenthal GmbH, Tissue Tech Inc., Kolon TissueGene, Inc., Bioventus LLC, Akan Biosciences, LLC, Genascence Corporation, Immunis, Inc., Novartis, Biosplice Therapeutics, Sorrento Therapeutics, Inc., Novartis, Celltex Therapeutics Corporation, MiMedx Group, Inc., Rho, Inc., Techfields Pharma Co. Ltd, Saol Therapeutics Inc, Centrexion Therapeutics, Taiwan Liposome Company, MiMedx, Ampio Pharmaceuticals, ReNu, Medipost, and others.
Knee Osteoarthritis Pipeline Analysis:
The Knee Osteoarthritis pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Knee Osteoarthritis with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Knee Osteoarthritis Treatment.
• Knee Osteoarthritis key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Knee Osteoarthritis Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Knee Osteoarthritis market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Download Sample PDF Report to know more about Knee Osteoarthritis drugs and therapies-
https://www.delveinsight.com/sample-request/knee-osteoarthritis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Knee Osteoarthritis Pipeline Market Drivers
• Increase in prevalence of Osteoarthritis, robust Knee Osteoarthritis Pipeline are some of the important factors that are fueling the Knee Osteoarthritis Market.
Knee Osteoarthritis Pipeline Market Barriers
• However, risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment, high cost associated with the treatment and other factors are creating obstacles in the Knee Osteoarthritis Market growth.
Scope of Knee Osteoarthritis Pipeline Drug Insight
• Coverage: Global
• Key Knee Osteoarthritis Companies: Merck KGaA, Peptinov, LG Chem, Akan Bioscience, BioTissue,Inc., Eupraxia Pharmaceuticals Inc., OliPass Corporation, Bone Therapeutics, Techfields Pharma, Biosplice Therapeutics, and others
• Key Knee Osteoarthritis Therapies: M6495, PPV 06, LG00034053, StroMel, TTAX03, EP-104IAR, OLP 1002, JTA-004, X 0002, Lorecivivint, and others
• Knee Osteoarthritis Therapeutic Assessment: Knee Osteoarthritis current marketed and Knee Osteoarthritis emerging therapies
• Knee Osteoarthritis Market Dynamics: Knee Osteoarthritis market drivers and Knee Osteoarthritis market barriers
Request for Sample PDF Report for Knee Osteoarthritis Pipeline Assessment and clinical trials-
https://www.delveinsight.com/sample-request/knee-osteoarthritis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. Knee Osteoarthritis Report Introduction
2. Knee Osteoarthritis Executive Summary
3. Knee Osteoarthritis Overview
4. Knee Osteoarthritis- Analytical Perspective In-depth Commercial Assessment
5. Knee Osteoarthritis Pipeline Therapeutics
6. Knee Osteoarthritis Late Stage Products (Phase II/III)
7. Knee Osteoarthritis Mid Stage Products (Phase II)
8. Knee Osteoarthritis Early Stage Products (Phase I)
9. Knee Osteoarthritis Preclinical Stage Products
10. Knee Osteoarthritis Therapeutics Assessment
11. Knee Osteoarthritis Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Knee Osteoarthritis Key Companies
14. Knee Osteoarthritis Key Products
15. Knee Osteoarthritis Unmet Needs
16 . Knee Osteoarthritis Market Drivers and Barriers
17. Knee Osteoarthritis Future Perspectives and Conclusion
18. Knee Osteoarthritis Analyst Views
19. Appendix
20. About DelveInsight
Related Reports:
Knee Osteoarthritis Market https://www.delveinsight.com/report-store/knee-osteoarthritis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Knee Osteoarthritis Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom).
Latest Reports:
Ischemia-reperfusion Injury Market https://www.delveinsight.com/report-store/ischemia-reperfusion-injury-market
DelveInsight's report titled "Ischemia-reperfusion injury Market Insights, Epidemiology, and Market Forecast - 2032" comprehensively analyzes historical and projected epidemiological data concerning Ischemia-reperfusion injury. This analysis includes a breakdown of the Incident Cases of Ischemia-reperfusion injury, Organ-specific Incident Cases of Ischemia-reperfusion injury, Gender-specific Incident Cases of Ischemia-reperfusion Injury, and Age-specific Incident Cases of Ischemia-reperfusion Injury.
Meniscus Tear Market
https://www.delveinsight.com/report-store/meniscus-tear-market
DelveInsight's report titled "Meniscus Tear Market Insights, Epidemiology, and Market Forecast -2032" provides a comprehensive analysis of Meniscus Tear. The report includes a detailed examination of the historical and projected epidemiology data that includes Total Incident Cases of Meniscus Tear, Gender-specific Incident Cases of Meniscus Tear, Age-specific Incident Cases of Meniscus Tear, Treatable Cases of Meniscus Tear.
Functional Dyspepsia Market https://www.delveinsight.com/report-store/functional-dyspepsia-market-insights
DelveInsight's "Functional Dyspepsia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Functional Dyspepsia, historical and forecasted epidemiology as well as the Functional Dyspepsia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Diphtheria Market
https://www.delveinsight.com/report-store/diphtheria-market
DelveInsight's report titled "Diphtheria Market Insights, Epidemiology, and Market Forecast - 2032" comprehensively analyzes diphtheria. The report includes a detailed examination of the historical and projected epidemiology data that includes incident cases of diphtheria segmented by age and type.
Chronic Constipation Market
https://www.delveinsight.com/report-store/chronic-constipation-market
DelveInsight's report titled "Chronic Constipation Market Insights, Epidemiology, and Market Forecast - 2032" comprehensively analyzes Chronic constipation. The report includes a detailed examination of the historical and projected epidemiology data, including Total Prevalent Cases, Diagnosed Prevalent Cases, Gender-specific Diagnosed Prevalent Cases, and Age-specific Diagnosed Prevalent cases of Chronic Constipation.
Pulmonary Fibrosis Market
https://www.delveinsight.com/report-store/pulmonary-fibrosis-market
DelveInsight's "Pulmonary Fibrosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Pulmonary Fibrosis, historical and forecasted epidemiology as well as the Pulmonary Fibrosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Contact Us:
Gaurav Bora
gbora@delveinsight.com
+91-9650213330
Healthcare Consulting
https://www.delveinsight.com/consulting-services
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Knee Osteoarthritis Pipeline Assessment, 2023 Updates: FDA, EMA, and PMDA Approvals, Emerging Drugs, Clinical Trials, Therapeutic Analysis, and Growth Prospects | Merck KGaA, Peptinov, LG Chem, Akan Bioscience, BioTissue,Inc., Eupraxia Pharmaceuticals Inc here
News-ID: 3343789 • Views: …
More Releases from DelveInsight Business Research
Global Advanced Melanoma Pipeline Accelerates With 60+ Emerging Therapies, Revea …
DelveInsight's "Advanced Melanoma Pipeline Insight 2025" report delivers an in-depth analysis of more than 55 companies and over 60 investigational therapies currently advancing through the Advanced Melanoma research landscape. It offers detailed profiles of both clinical- and preclinical-stage candidates and provides a thorough evaluation of therapies based on product type, development stage, route of administration, and molecule class. The report also outlines inactive or discontinued programs within this domain.
Explore the…
Global Spasticity Treatment Landscape Set for Transformation: DelveInsight Unvei …
DelveInsight's "Spasticity Pipeline Insight, 2025" report offers an in-depth evaluation of 10+ companies and more than 12 investigational therapies currently advancing through the Spasticity treatment pipeline. The report includes detailed profiles of clinical- and preclinical-stage candidates, along with a thorough assessment of therapies by product type, development phase, route of administration, and molecular class. It also highlights discontinued and inactive programs in the field.
Stay informed with the latest developments! Access…
Lewy Body Dementia Treatment Market 2034 - Market Size, Competitive Landscape, C …
The Lewy Body Dementia (LBD) market across the seven major markets (7MM) was valued at approximately USD 670 million in 2022, with strong growth anticipated through 2034. In 2022, an estimated 11 million dementia cases were recorded across the 7MM, of which ~0.6 million were attributed to Lewy Body Dementia. Rising disease prevalence-driven by aging demographics, enhanced diagnostic capabilities, and increasing awareness-is expected to stimulate market expansion. Companies including EIP…
Bronchitis Treatment Market 2034: Market Size, Competitive Landscape, Companies, …
The bronchitis therapeutics market is projected to grow steadily from 2025-2034, driven by rising disease prevalence, technological progress, and the emergence of new treatment options. Current management focuses on symptom relief through bronchodilators, corticosteroids, and antibiotics for acute cases, while chronic bronchitis requires long-term inhaled therapies, pulmonary rehabilitation, and lifestyle changes. A key advancement is the FDA-approved OHTUVAYRE (ensifentrine), which offers dual bronchodilator and anti-inflammatory benefits. Despite progress, there is…
More Releases for Knee
Knee Pain Relief Codes: The Ultimate Guide to Overcoming Knee Pain Naturally
The Knee Pain Relief Codes is a comprehensive online program designed to help individuals prevent and alleviate knee pain through proactive and natural methods. It provides valuable information on maintaining knee health, strengthening knee joints, and managing pain effectively. The program focuses on relieving joint discomfort, stiffness, and knee osteoarthritis using simple yet powerful exercises and techniques.
While knee pain is common, some conditions like knee osteoarthritis and joint injuries can…
Nooro Knee Massager Reviews 2024: How Does Nooro Knee Massager Work? Important U …
Nooro Knee Massager Reviews 2024: How Does Nooro Knee Massager Work? Important Update About Nooro Knee Massager, Buyers Beware!!!
Introducing the groundbreaking Nooro Knee Massager - a cutting-edge solution meticulously designed by leading knee pain experts. Experience unparalleled relief precisely when you need it, as this revolutionary device combines Red Light Therapy, Heat Therapy, and Massage Therapy for a holistic approach to knee discomfort. Not only is it remarkably cost-effective, but…
NOORO KNEE MASSAGER REVIEW 2023: BUYERS BEWARE! IS NOORO KNEE MASSAGER LEGIT?
In a world where knee discomfort has become increasingly prevalent, seeking effective solutions for pain relief has never been more important. Middle-aged and older individuals, in particular, often find themselves grappling with knee pain, hindering their daily activities and overall quality of life. This is where the Nooro Knee Massager steps in as a beacon of hope, offering targeted relief and relaxation for weary and sore knees. In this comprehensive…
Knee Walker Market - Revolutionizing Rehabilitation: Knee Walker's Impact on the …
Newark, New Castle, USA: The "Knee Walker Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Knee Walker Market: https://www.growthplusreports.com/report/knee-walker-market/8893
This latest report researches the industry structure, sales, revenue,…
Knee Sleeve Review 2022: (Must Read!) Is Knee Sleeve Working or Fake?
As people become older, the lubrication that surrounds their knee caps wears off, making them more susceptible to injury.
The pain may eventually become intolerable with long-distance walking, frequent use of the knee, particularly on rough surfaces, and other daily activities.
When this happens, a person can discover that they are unable to continue with their regular routines.
To solve this problem, get our Knee Sleeves and use them in…
Knee Orthosis Market Increasing Demand By Type: With Knee Pads, Knee Has Opening …
Acumen Research and Consulting has announced the addition of the "Knee Orthosis Market” report to their offering.
The Knee Orthosis Market Report 2018 is an in depth study analyzing the current state of the Knee Orthosis Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Knee Orthosis Market provides analysis of China market covering the industry trends, recent…
